Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy

被引：0
|
作者：
C G McMahon
机构：
[1] Australian Centre for Sexual Health,
来源：
International Journal of Impotence Research | 2003年 / 15卷
关键词：
erectile dysfunction; priapism; sildenafil; tadalafil; penile injections;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：383 / 384
页数：1
相关论文
共 50 条
  • [31] Phosphodiesterase Type 5 Inhibitor Use Following Radical Prostatectomy is not Associated with an Increased Risk of Biochemical Recurrence
    Jung Ki Jo
    Kwangmo Kim
    Sang Eun Lee
    Jung Keun Lee
    Seok-Soo Byun
    Sung Kyu Hong
    Annals of Surgical Oncology, 2016, 23 : 1760 - 1767
  • [32] Transient phototoxic skin reaction in psoriatic patient treated with selective phosphodiesterase it inhibitor without discontinuing the use of systemic drugs
    Valiukeviciene, S.
    Bubilaite, A.
    Stragyte, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 70 - 70
  • [33] Decreased persistence to cholinesterase inhibitor therapy with concomitant use of drugs that can impair cognition
    Kogut, SJ
    El-Maouche, D
    Abughosh, SM
    PHARMACOTHERAPY, 2005, 25 (12): : 1729 - 1735
  • [34] PHOSPHODIESTERASE TYPE-5 INHIBITOR USE IN TYPE 2 DIABETES IS ASSOCIATED WITH A REDUCTION IN ALL CAUSE MORTALITY
    Heald, A.
    Hackett, G.
    Hutchings, D.
    Hackett, G.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 192 - 193
  • [35] EFFECT OF DAILY PHOSPHODIESTERASE 5 INHIBITOR USE ON TRIMIX INTRACORPOREAL INJECTION DOSAGE IN MEN WITH SEXUAL DYSFUNCTION FOLLOWING RADICAL PROSTATECTOMY
    Alla, K. Khalaf
    Mahdi, M.
    Majzoub, A.
    Jacob, J.
    Slovacek, H.
    Wang, R.
    JOURNAL OF SEXUAL MEDICINE, 2024, 21
  • [36] Cardiovascular Risk Associated With Concurrent Proton Pump Inhibitor and Clopidogrel Therapy: How Much? How Specific?
    Hall, Nathaniel L.
    Mathews, Katy D.
    May, Heidi T.
    Bair, Tami L.
    Horne, Benjamin D.
    Carlquist, John F.
    Lappe, Donald L.
    Muhlestein, Joseph B.
    Anderson, Jeffrey L.
    CIRCULATION, 2009, 120 (18) : S422 - S422
  • [37] Initiation into prescription opioid injection and associated trends in heroin use among people who use illicit drugs
    Lake, Stephanie
    Milloy, M-J
    Dong, Huiru
    Hayashi, Kanna
    Wood, Evan
    Kerr, Thomas
    DeBeck, Kora
    DRUG AND ALCOHOL DEPENDENCE, 2016, 169 : 73 - 79
  • [38] Rising role of prescription drugs as a portal to injection drug use and associated mortality in Baltimore, Maryland
    Cepeda, Javier A.
    Astemborski, Jacquie
    Kirk, Gregory D.
    Celentano, David D.
    Thomas, David L.
    Mehta, Shruti H.
    PLOS ONE, 2019, 14 (03):
  • [39] Phosphodiesterase Type-5 Inhibitor Use in Type 2 Diabetes Is Associated with a Reduction in All-Cause Mortality
    Anderson, Simon G.
    Hutchings, David C.
    Trafford, Andrew W.
    Heald, Adrian H.
    DIABETES, 2015, 64 : A412 - A412
  • [40] Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor Use
    Li, Albert S.
    Pomeranz, Howard D.
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2016, 36 (04) : 480 - 481
12345